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Ambulatory Medical Care Utilization 
Estimates for 2006 
by Susan M. Schappert, M.A., and Elizabeth A. Rechtsteiner, M.S., Division of Health Care Statistics Abstract 
Objectives—This report presents statistics on ambulatory care visits to 
physician offices, hospital outpatient departments (OPDs), and hospital 
emergency departments (EDs) in the United States in 2006. Ambulatory medical 
care utilization is described in terms of patient, practice, facility, and visit 
characteristics. 
Methods—Data from the 2006 National Ambulatory Medical Care Survey 
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) 
were combined to produce annual estimates of ambulatory medical care 
utilization. 
Results—Patients in the United States made an estimated 1.1 billion visits to 
physician offices and hospital OPDs and EDs, a rate of 381.9 visits per 100 
persons annually. The overall visit rate was not significantly different for white 
and black persons. However, black persons had higher visit rates than white 
persons to hospital OPDs and EDs and lower visit rates to office-based surgical 
and medical specialists. Visit distribution by ambulatory care setting differed by 
poverty level in the patient’s ZIP Code of residence, with higher proportions of 
visits to hospital OPDs and EDs as poverty levels increased. Between 1996 and 
2006, visit rates to medical specialty offices climbed overall by 29 percent, with 
a significant increase noted for white patients but not black patients. The rate of 
OPD visits jumped from 25.4 visits per 100 persons in 1996 to 34.7 in 2006, 
whereas ED visits during the same period increased from 34.1 to 40.5 per 100 
persons. About 18.3 percent of all ambulatory care visits in 2006 were for 
nonillness or noninjury conditions, such as routine checkups and pregnancy 
exams. Seven in ten ambulatory care visits had at least one medication provided, 
prescribed, or continued in 2006, for a total of 2.6 billion drugs overall. 
Analgesics were the most common therapeutic category, accounting for 13.6 
drugs per 100 drugs prescribed, and they were most often utilized at primary 
care and ED visits. The percentage of visits at which medication was prescribed 
increased significantly in most settings between 1996 and 2006. 
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National Center for Health StatisticsIntroduction 
This report presents summary 
information on the utilization of 
ambulatory medical care across 
physician offices and hospital 
emergency departments (EDs) and 
outpatient departments (OPDs). 
Physician offices are further classified 
by the physician specialty: primary care, 
surgical, and medical. The tables present 
total visits across all settings as well as 
percent distributions by setting type. 
Data are from NAMCS and NHAMCS, 
which are part of the ambulatory care 
component of the National Health Care 
Surveys, a family of provider-based 
surveys conducted by the Centers for 
Disease Control and Prevention’s 
National Center for Health Statistics. 
Methods 
Estimates of ambulatory medical 
care use are based on national 
probability provider-based surveys of 
visits to nonfederal office-based 
physicians and EDs and OPDs of 
nonfederal general and short-stay 
hospitals in the 50 states and the District 
of Columbia. Individual reports are 
available that contain detailed methods 
and analyses by setting: physician ERVICES 
tion 
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1Significant change (p < 0.05). 




















Figure 2. Age-adjusted ambulatory care visit rates by setting: United States, 1996 and 
2006 offices (1), OPDs (2), and EDs (3). 
These reports, issued annually, provide a 
comprehensive analysis of visits to 
ambulatory health care settings in the 
United States. Estimates of visits are 
made from a sample of medical record 
abstracts from each sampled provider 
during defined reporting periods. Sample 
data are weighted to provide national 
annual estimates. More information on 
the sampling design and scope of the 
surveys can be found at www.cdc.gov/ 
nchs/about/major/ahcd/ahcd1.htm. 
Results 
There were 1.1 billion visits to 
physician offices and hospital EDs and 
OPDs in the United States during 2006, 
a rate of 381.9 visits per 100 persons 
annually. Nearly one-half of ambulatory 
medical care visits (46.8 percent) were 
made to primary care physicians in 
office-based practices. The rest of the 
visits were to medical specialists 
(17.7 percent) and surgical specialists 
(15.8 percent) in office-based practices 
and to EDs (10.6 percent) and OPDs 
(9.1 percent) in nonfederal general and 
short-stay hospitals (Table 1). Visit rates 
by setting for 2006 were consistent with 
2005 (Table 2). 
From 1996–2006, the number of 
ambulatory care visits overall increased 
by 26 percent (Figure 1), faster than the 
growth of the U.S. population, which 
rose by 11 percent. The apparent decline 
in visits between 2005 and 2006 was 
not statistically significant. The overall 
number of ED visits was up 32 percent 
between 1996 and 2006, whereas the 
number of OPD visits jumped by 
52 percent (data not shown). The 
disproportionate rise in visits can be 
linked both to the aging of the 
population (as older people have higher 
visit rates than younger persons in 
general) and to an increase in utilization 
by older persons. After adjustment for 
changes in the age distribution between 
1996 and 2006, visit rates increased by 
11 percent. This was driven by 
increasing rates of visits to OPDs (up 
35 percent), medical specialties (up 
23 percent), and EDs (up 19 percent). Age-adjusted visit rates are shown in 
Figure 2. 
In 2006, the overall visit rate for 
white persons (391.3 visits per 100 persons) and black persons (378.8) was 
not significantly different. However, 
black persons had higher visit rates than 
white persons to hospital OPDs and EDs 
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surgical and medical specialists 
(Table 2). The total visit rate for 
Hispanics (346.5 visits per 100 persons) 
was not significantly different from that 
for non-Hispanics (388.0 visits per 100 
persons) in 2006, although Hispanics 
had slightly lower visit rates to 
nonprimary care physicians than 
non-Hispanics. 
Between 1996 and 2006, the 
age-adjusted rate of visits by white 
persons to medical specialists increased 
by 28 percent (Figure 3). However, the 
increase was most pronounced between 
1996 and 2001, when rates climbed by 
45 percent. Age-adjusted rates to 
hospital OPDs and EDs also increased 
significantly for white persons, by about 






























































NOTE: Test of trend is significant for visits by white and black pe
SOURCES: CDC/NCHS, National Ambulatory Medical Care Surv
Figure 3. Age-adjusted ambulatory care visit ra
United States, 1996–2006 (EDs). For black persons, the age-
adjusted rate of visits to EDs increased 
by about 40 percent, from 58 visits per 
100 persons in 1996 to 81 visits per 100 
persons in 2006, but no significant trend 
was found in the rates of OPD visits or 
medical specialty visits. Hospital EDs 
typically serve as safety-net providers to 
those without access to other types of 
health care. 
As in 2005, visit rates for persons 
with no insurance for the care provided 
(i.e., expected payment from solely 
self-pay, no charge, or charity) were 
lowest for all office-based settings 
compared with visit rates for persons 
with various kinds of insurance. In 
contrast, the visit rate to EDs for the 
uninsured (47.4 visits per 100 persons) 













rsons (p < 0.05). 
ey and National Hospital Ambulatory Medical Care Survey. 
tes by patient race for selected settings: private insurance (24.9 visits per 100 
persons) (Table 2). 
Although NAMCS and NHAMCS 
do not collect data on the 
socioeconomic status of the patient, the 
surveys do collect the patient’s ZIP 
Code of residence. U.S. Census Bureau 
demographic data for ZIP Codes can be 
used in conjunction with survey data to 
examine the relationship between 
characteristics of the patient’s ZIP Code 
of residence and the choice of 
ambulatory medical care setting. Table 3 
and Figure 4 show data on ambulatory 
care visits according to demographic 
characteristics of the patient’s ZIP Code 
of residence. Ambulatory care setting (as 
shown in Table 3) was significantly 
associated with poverty level (X2 = 
70.88, df = 12, and p < 0.01), 
educational level (X2 = 59.46, df = 12, 
and p < 0.01) and median household 
income (X2 = 62.39, df = 12, and 
p < 0.01) in the patient’s ZIP Code of 
residence. 
For persons living in areas where 
the poverty level was below 20 percent, 
81.7 percent of visits were to physician 
offices. The proportion of visits to 
office-based physicians steadily 
decreased as the percentage of residents 
living in poverty increased. For 
example, for patients living in areas 
with more than 40 percent of the 
residents living below the poverty level, 
only 54.2 percent of visits were to 
office-based physicians. Conversely, the 
proportion of visits to hospital settings 
rose steadily with increases in poverty 
level. For patients in the poorest areas 
(40 percent poverty level or higher), 
45.8 percent of the visits were to 
hospital settings. Similar patterns were 
noted for median household income and 
education, with higher levels of both 
more likely to be associated with higher 
percentages of visits to office-based 
physicians. Additional logistic regression 
analysis was performed to analyze the 
effects of race, expected source of 
payment, and percentage of poverty in 
the patient’s ZIP Code as predictors of 
ambulatory care setting. Results showed 
that each of these variables had 
significant effects and that race 
remained significant even after 
Physician offices Outpatient departments Emergency departments 













SOURCES: CDC/NCHS, National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. 
Figure 4. Percent distribution of ambulatory care visits by setting according to poverty level in patient’s ZIP Code: United States, 2006 
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poverty level (data not shown). 
Essential hypertension was the 
primary illness diagnosis recorded most 
frequently (40.5 million) at ambulatory 
care visits. About three-fourths (30.7 
million) of these occurred in primary 
care offices, accounting for 5.8 percent 
of the 525.6 million visits to this setting 
in 2006. About 18.3 percent of all 
ambulatory care visits in 2006 had 
diagnoses of nonillness or noninjury 
conditions, such as routine checkups and 
pregnancy exams. No significant 
differences were noted among the top 
35 diagnoses between 2005 and 2006, 
with the exception of a slight decrease 
in visits for chest pain, from 0.9 percent 
to 0.7 percent. Table 4 shows the 35 
leading diagnoses by setting, and 
Table 5 shows the complete 
classification of primary diagnoses 
ordered by diagnosis group with breakdowns across ambulatory care 
settings. Because of the detail shown in 
Table 5, estimates from 2005 and 2006 
were averaged to improve reliability. 
The classification scheme used in 
Table 5 is described in Table A. 
In 2006, medication therapy was 
reported at 71.6 percent of all 
ambulatory care visits. An estimated 2.6 
billion medications, including over-the­
counter preparations, immunizations, 
allergy shots, anesthetics, and dietary 
supplements, were provided, prescribed, 
or continued at ambulatory care visits 
(Table 6). Each such occurrence is 
referred to as a ‘‘drug mention’’ in 
NAMCS and NHAMCS. Central 
nervous system agents were the most 
common therapeutic category (22.5 
drugs per 100 drug mentions). Within 
that group, analgesics were most 
frequently reported, accounting for 13.6 
drugs per 100 mentions and were most often utilized at primary care and ED 
visits (Tables 7 and 8). Among the broad 
therapeutic classes, cardiovascular 
agents (15.4 mentions per 100 drugs) 
and respiratory agents (9.6 mentions per 
100 drugs) were also prominent. The 
use of drug therapy increased 
significantly between 1996 and 2006 at 
all settings except surgical specialties 
(Figure 5). 
It should be noted that, starting with 
the 2006 data release, drugs collected in 
NAMCS and NHAMCS are being coded 
in terms of their generic components 
and therapeutic classifications using 
Lexicon Plus®, a proprietary database of 
Cerner Multum, Inc. The Lexicon Plus 
is a comprehensive database of all 
prescription and some nonprescription 
drug products available in the U.S. drug 
market. Because of this change, 
therapeutic class information presented 
in this report will not be comparable 

















1Significant change (p < 0.05). 



















Figure 5. Percentage of visits where medication was prescribed, by ambulatory care 
setting: United States, 1996 and 2006 with previous years of data, which were 
coded using the National Drug Code 
Directory. More information about the 
Multum Lexicon and how researchers 
can do drug trend analysis with 
NAMCS and NHAMCS data is 
available at www.cdc.gov/nchs/about/ 
major/ahcd/ahcd1.htm. For additional 
information on the Multum Lexicon 
Drug Database, please refer to the following website: 
www.multum.com/Lexicon.htm. 
Data on characteristics of physicians 
and their office-based practices have 
recently been published (4). Public-use 
micro-data visit files for 2006 are 
available for downloading from 
www.cdc.gov/nchs/about/major/ahcd/ 
ahcd1.htm. In addition, new information 
from the 2006 National Survey of Ambulatory Surgery on 
ambulatory surgical procedures in both 
hospital and freestanding centers is 
currently in press. 
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Table A. Reclassification of primary diagnosis 
Ambulatory Medical Care Survey data: United 
codes 
States, 
for use with 
2005–2006 
National Ambulatory Medical Care Survey and National Hospital 
Primary diagnosis  ICD–9–CM code1
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
HIV infection2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . . . .  
Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of colon and rectum . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of lymphatic and hematopoietic tissue . . . . . . . . . . . . . . . .  
Other malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other benign neoplasm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neoplasm of uncertain behavior and unspecified nature . . . . . . . . . . . . . . . . . .  
Endocrine, nutritional and metabolic diseases, and immunity disorders . . . . . . . . . . .  
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the thyroid gland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of lipoid metabolism. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other endocrine, nutritional and metabolic diseases, and immunity disorders . . . . .  
Diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . . . . . . . . . .  
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the blood and blood-forming organs. . . . . . . . . . . . . . . . . . .  
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Schizophrenic disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Alcohol dependence syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Drug dependence and nondependent use of drugs . . . . . . . . . . . . . . . . . . . . .  
Acute reaction to stress and adjustment reaction . . . . . . . . . . . . . . . . . . . . . .  
Depressive disorder, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . .  
Attention deficit disorder  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . . . . . . . . . .  
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the central nervous system . . . . . . . . . . . . . . . . . . . . . . .  
Carpal tunnel syndrome. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . . .  
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of refraction and accommodation . . . . . . . . . . . . . . . . . . . . . . . . .  
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the eye and adnexa . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Otitis media and eustachian tube disorders. . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the ear and mastoid process . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Coronary atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cardiac dysrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
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Table A. Reclassification of primary diagnosis codes for use with National Ambulatory Medical Care Survey and National Hospital 
Ambulatory Medical Care Survey data: United States, 2005–2006—Con. 
Primary diagnosis  ICD–9–CM code1
Congestive heart failure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  428.0
 
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  391–392.0,393–398,402,404,415–416,420–426,428.1–429
 
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  401
 
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  430–438
 
Diseases of the arteries, arterioles, and capillaries . . . . . . . . . . . . . . . . . . . . . 440–448
 
Hemorrhoids. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  455 
  
Other diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . .  390,392.9,403,405,417,451–454,456–459
 
Diseases of the respiratory system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  460–519
 
Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  461
 
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  462 
  
Acute tonsillitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  463
 
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  466 
  
Other acute respiratory infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  460,464–465
 
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  473 
  
Allergic rhinitis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  477 
  
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  480–486
 
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  490–491
 
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  493 
  
Other chronic obstructive pulmonary disease and allied conditions . . . . . . . . . . . 492,494–496
 
Other diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . . .  470–472,474–476,478,487,500–519
 
Diseases of the digestive system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  520–579
 
Diseases of the teeth and supporting structures . . . . . . . . . . . . . . . . . . . . . . . 520–525
 
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  535 
  
Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  530.1
 
Ulcer of stomach and small intestine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  531–534
 
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  550–553
 
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  555–558
 
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  562 
  
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  564.0
 
Irritable bowel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  564.1
 
Anal and rectal diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  565–566,569.0–569.4
 
Disorders of the gallbladder and biliary tract . . . . . . . . . . . . . . . . . . . . . . . . . 574–576
 
Gastrointestinal hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  578 
  
Other diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . . . .  526.0–530.0,530.2–530.9,536–543,560,564.2–564.9,
 
576–568,569.5–573.9,577,579 
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  580–629
 
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  592
 
Cystitis and other disorders of the bladder . . . . . . . . . . . . . . . . . . . . . . . . . .  595–596
 
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . . .  599.0
 
Other diseases of the urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  580–589,590–591,593–594,597–598,599.1–599.9
 
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  600
 
Other disorders of male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  601–608
 
Disorders of breast. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  610–611
 
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . . . . 614–616
 
Noninflammatory disorders of female genital organs . . . . . . . . . . . . . . . . . . . . 620,622–624
 
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . . . 626
 
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . . . . 627
 
Other disorders of the female genital tract . . . . . . . . . . . . . . . . . . . . . . . . . .  617–619,621,625,628,629
 
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . . . . . 630–677
 
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . . . . . 680–709
 
Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  681–682
 
Other infection of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . 680,683–686
 
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  692 
  
Psoriasis and similar disorders  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  696 
  
Other inflammatory conditions of skin and subcutaneous tissue . . . . . . . . . . . . . 690–691,693–695,697–698
 
Corns, callosities, and other hypertrophic and atrophic skin conditions . . . . . . . . . 700–701
 
Actinic and seborrheic keratosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  702.0–702.1
 
Acne  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  706.0–706.1
 
Sebaceous cyst. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  706.2
 
Urticaria  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  708 
  
Other disorders of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . 702.8,703–705,706.3–707.9,709
 
See footnotes at end of table. 
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Table A. Reclassification of primary diagnosis 
Ambulatory Medical Care Survey data: United 
codes 
States, 
for use with National 
2005–2006—Con. 
Ambulatory Medical Care Survey and National Hospital 
Primary diagnosis  ICD–9–CM code1
Diseases of the musculoskeletal system and connective tissue . . . . . . . . . . . . . . . .
Rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other arthropathies and related disorders. . . . . . . . . . . . . . . . . . . . . . . . . . .
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . .
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lumbago . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other dorsopathies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . . .
Synovitis and tenosynovitis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Myalgia and myositis, unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Disorders of bone and cartilage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other diseases of the musculoskeletal system and connective tissue. . . . . . . . . .
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Certain conditions originating in the perinatal period . . . . . . . . . . . . . . . . . . . . . . .
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Syncope and collapse. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dizziness and giddiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Symptoms involving skin and other integumentary tissue . . . . . . . . . . . . . . . . .
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dyspnea and respiratory abnormalities . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Symptoms involving urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other symptoms, signs and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . .
Injury and poisoning. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fracture of radius and ulna  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fracture of hand and fingers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sprains and strains of wrist and hand . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sprains and strains of knee and leg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sprains and strains of ankle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other sprains and strains of back. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other sprains and strains. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intracranial injury, excluding those with skull fracture . . . . . . . . . . . . . . . . . . . .
Open wound of head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Open wound of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Superficial injury of cornea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Contusion with intact skin surface  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other and unspecified effects of external causes . . . . . . . . . . . . . . . . . . . . . .
Complications of surgical and medical care, not elsewhere classified . . . . . . . . . .
Supplementary classification of factors influencing health status and contact
 
with health services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Potential health hazards related to communicable diseases . . . . . . . . . . . . . . .
Potential health hazards related to personal and family history. . . . . . . . . . . . . .
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Postpartum care and examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Table A. Reclassification of primary diagnosis 
Ambulatory Medical Care Survey data: United 
codes 
States, 
for use with National 
2005–2006—Con. 
Ambulatory Medical Care Survey and National Hospital 
Primary diagnosis	 ICD–9–CM  code1
Encounter for contraceptive management. . . . . . . . . . . . . . . . . . . . . . . . . . .
Other encounter related to reproduction . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . .
Attention to surgical dressing and sutures . . . . . . . . . . . . . . . . . . . . . . . . . .
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Observation and evaluation for suspected conditions not found . . . . . . . . . . . . .
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .



















	  V20.0–V20.1,V21,V29.0–V43.0,V43.2–V43.8,V46–V66,V68–V69, 
V72.0–V72.2,V72.4–V82.9 
1Based on the
2HIV is human 
 International Classification 
immunodeficiency virus. 
of Diseases, Ninth Revision, Clinical Modification (5). 
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Table 1. Number and percent distribution 
characteristics: United States, 2006 



















All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . .  
Under 1 year . . . . . . . . . . . . . . . . . . .  
1–4 years . . . . . . . . . . . . . . . . . . . . .  
5–14 years. . . . . . . . . . . . . . . . . . . . .  
15–24 years . . . . . . . . . . . . . . . . . . . . .  
25–44 years . . . . . . . . . . . . . . . . . . . . .  
45–64 years . . . . . . . . . . . . . . . . . . . . .  
65 years and over . . . . . . . . . . . . . . . . .  
65–74 years . . . . . . . . . . . . . . . . . . . .  
75 years and over . . . . . . . . . . . . . . . .  
Patient sex 
Female  . . . . . . . . . . . . . . . . . . . . . . . .  
Male  . . . . . . . . . . . . . . . . . . . . . . . . . .  
1 Patient race
White  . . . . . . . . . . . . . . . . . . . . . . . . .  
Black  or  African  American  . . . . . . . . . . . . .  
Asian  . . . . . . . . . . . . . . . . . . . . . . . . .  
Native Hawaiian or Other Pacific Islander . . . 
American Indian or Alaska Native . . . . . . . .  
Two or more races reported . . . . . . . . . . .  
Patient ethnicity 
Hispanic or Latino. . . . . . . . . . . . . . . . . .  
Not Hispanic or Latino . . . . . . . . . . . . . . .  
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . .  
Medicare  . . . . . . . . . . . . . . . . . . . . . . .  
Medicare  and  Medicaid  . . . . . . . . . . . . .  
 Medicaid or SCHIP2 . . . . . . . . . . . . . . . .  
 No insurance3 . . . . . . . . . . . . . . . . . . . .  
Self-pay  . . . . . . . . . . . . . . . . . . . . . .  
No charge or charity . . . . . . . . . . . . . . .  
Worker’s compensation . . . . . . . . . . . . . .  
Other  . . . . . . . . . . . . . . . . . . . . . . . . .  
Unknown or blank. . . . . . . . . . . . . . . . . .  
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . .  
Midwest  . . . . . . . . . . . . . . . . . . . . . . . .  
South  . . . . . . . . . . . . . . . . . . . . . . . . .  
West  . . . . . . . . . . . . . . . . . . . . . . . . . .  
 MSA4 status of provider 
MSA  . . . . . . . . . . . . . . . . . . . . . . . . . .  
Not  MSA  . . . . . . . . . . . . . . . . . . . . . . .  
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Table 1. Number and percent distribution of 
characteristics: United States, 2006—Con. 



















All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . .  
Under 1 year . . . . . . . . . . . . . . . . . . .  
1–4 years . . . . . . . . . . . . . . . . . . . . .  
5–14 years. . . . . . . . . . . . . . . . . . . . .  
15–24 years . . . . . . . . . . . . . . . . . . . . .  
25–44 years . . . . . . . . . . . . . . . . . . . . .  
45–64 years . . . . . . . . . . . . . . . . . . . . .  
65 years and over . . . . . . . . . . . . . . . . .  
65–74 years . . . . . . . . . . . . . . . . . . . .  
75 years and over . . . . . . . . . . . . . . . .  
Patient sex 
Female  . . . . . . . . . . . . . . . . . . . . . . . .  
Male  . . . . . . . . . . . . . . . . . . . . . . . . . .  
1 Patient race
White  . . . . . . . . . . . . . . . . . . . . . . . . .  
Black  or  African  American  . . . . . . . . . . . . .  
Asian  . . . . . . . . . . . . . . . . . . . . . . . . .  
Native Hawaiian or Other Pacific Islander . . . 
American Indian or Alaska Native . . . . . . . .  
Two or more races reported . . . . . . . . . . .  
Patient ethnicity 
Hispanic or Latino. . . . . . . . . . . . . . . . . .  
Not Hispanic or Latino . . . . . . . . . . . . . . .  
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . .  
Medicare  . . . . . . . . . . . . . . . . . . . . . . .  
Medicare  and  Medicaid  . . . . . . . . . . . . .  
 Medicaid or SCHIP2 . . . . . . . . . . . . . . . .  
 No insurance3 . . . . . . . . . . . . . . . . . . . .  
Self-pay  . . . . . . . . . . . . . . . . . . . . . .  
No charge or charity . . . . . . . . . . . . . . .  
Worker’s compensation . . . . . . . . . . . . . .  
Other  . . . . . . . . . . . . . . . . . . . . . . . . .  
Unknown or blank. . . . . . . . . . . . . . . . . .  
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . .  
Midwest  . . . . . . . . . . . . . . . . . . . . . . . .  
South  . . . . . . . . . . . . . . . . . . . . . . . . .  
West  . . . . . . . . . . . . . . . . . . . . . . . . . .  
 MSA4 status of provider 
MSA  . . . . . . . . . . . . . . . . . . . . . . . . . .  
































































































































































































































* Figure does not meet standards of reliability or precision.
 
1The race groups White, Black or African American, Asian, Native Hawaiian or Other Pacific Islander, American Indian or Alaska Native, and multiple races include persons of Hispanic and non-

Hispanic origin. Persons of Hispanic origin may be of any race. Starting with data year 1999, race-specific estimates have been tabulated according to the 1997 Standards for Federal Data on
 
Race and Ethnicity and are not strictly comparable with estimates for earlier years. The percentage of visit records with multiple races indicated is small and lower than is typically found for
 
self-reported race in household surveys.
 
2SCHIP is State Children’s Health Insurance Program.
 
3No insurance is defined as having only self-pay, no charge, or charity as payment sources.
 
4MSA is metropolitan statistical area.
 
NOTES: The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based physicians. Estimates 
presented in this table include data from office-based physicians as defined by the American Medical Association as well as data from a sample of physicians working in CHCs. 
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Table 2. Rate of 
characteristics: 
ambulatory care visits 
United States, 2006 



















All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . .  
Under 1 year . . . . . . . . . . . . . . . . . . .  
1–4 years . . . . . . . . . . . . . . . . . . . . .  
5–14 years. . . . . . . . . . . . . . . . . . . . .  
15–24 years . . . . . . . . . . . . . . . . . . . . .  
25–44 years . . . . . . . . . . . . . . . . . . . . .  
45–64 years . . . . . . . . . . . . . . . . . . . . .  
65 years and over . . . . . . . . . . . . . . . . .  
65–74 years . . . . . . . . . . . . . . . . . . . .  
75 years and over . . . . . . . . . . . . . . . .  
Patient sex 
Female  . . . . . . . . . . . . . . . . . . . . . . . .  
Male  . . . . . . . . . . . . . . . . . . . . . . . . . .  
4 Patient race
White  . . . . . . . . . . . . . . . . . . . . . . . . .  
Black  or  African  American  . . . . . . . . . . . . .  
Asian  . . . . . . . . . . . . . . . . . . . . . . . . .  
Native Hawaiian or Other Pacific Islander . . . 
American Indian or Alaska Native . . . . . . . .  
Two or more races reported . . . . . . . . . . .  
Patient ethnicity 
Hispanic or Latino. . . . . . . . . . . . . . . . . .  
Not Hispanic or Latino . . . . . . . . . . . . . . .  
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . .  
Medicare  . . . . . . . . . . . . . . . . . . . . . . .  
 Medicaid or SCHIP5 . . . . . . . . . . . . . . . .  
 No insurance6 . . . . . . . . . . . . . . . . . . . .  
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . .  
Midwest  . . . . . . . . . . . . . . . . . . . . . . . .  
South  . . . . . . . . . . . . . . . . . . . . . . . . .  
West  . . . . . . . . . . . . . . . . . . . . . . . . . .  
 MSA7 status of provider 
MSA  . . . . . . . . . . . . . . . . . . . . . . . . . .  
Not  MSA  . . . . . . . . . . . . . . . . . . . . . . .  
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Table 2. Rate of 
characteristics: 
ambulatory care visits with 
United States, 2006—Con. 



















All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . .  
Under 1 year . . . . . . . . . . . . . . . . . . .  
1–4 years . . . . . . . . . . . . . . . . . . . . .  
5–14 years. . . . . . . . . . . . . . . . . . . . .  
15–24 years . . . . . . . . . . . . . . . . . . . . .  
25–44 years . . . . . . . . . . . . . . . . . . . . .  
45–64 years . . . . . . . . . . . . . . . . . . . . .  
65 years and over . . . . . . . . . . . . . . . . .  
65–74 years . . . . . . . . . . . . . . . . . . . .  
75 years and over . . . . . . . . . . . . . . . .  
Patient sex 
Female  . . . . . . . . . . . . . . . . . . . . . . . .  
Male  . . . . . . . . . . . . . . . . . . . . . . . . . .  
4 Patient race
White  . . . . . . . . . . . . . . . . . . . . . . . . .  
Black  or  African  American  . . . . . . . . . . . . .  
Asian  . . . . . . . . . . . . . . . . . . . . . . . . .  
Native Hawaiian or Other Pacific Islander . . . 
American Indian or Alaska Native . . . . . . . .  
Two or more races reported . . . . . . . . . . .  
Patient ethnicity 
Hispanic or Latino. . . . . . . . . . . . . . . . . .  
Not Hispanic or Latino . . . . . . . . . . . . . . .  
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . .  
Medicare  . . . . . . . . . . . . . . . . . . . . . . .  
 Medicaid or SCHIP5 . . . . . . . . . . . . . . . .  
 No insurance6 . . . . . . . . . . . . . . . . . . . .  
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . .  
Midwest  . . . . . . . . . . . . . . . . . . . . . . . .  
South  . . . . . . . . . . . . . . . . . . . . . . . . .  
West  . . . . . . . . . . . . . . . . . . . . . . . . . .  
 MSA7 status of provider 
MSA  . . . . . . . . . . . . . . . . . . . . . . . . . .  





























































































































































































* Figure does not meet standards of reliability or precision.
 




2Population estimates of metropolitan statistical area status are based on data from the 2006 National Health Interview Survey, National Center for Health Statistics, adjusted to the U.S. Census
 
Bureau definition of core-based statistical areas as of December 2006. See www.census.gov/population/www/estimates/metrodef.html for more about metropolitan statistical definitions.
 
3Population estimates for expected source of payment are based on the data from the 2006 National Health Interview Survey.
 
4The race groups White, Black or African American, Asian, Native Hawaiian or Other Pacific Islander, American Indian or Alaska Native, and multiple races include persons of Hispanic and non-

Hispanic origin. Persons of Hispanic origin may be of any race. Starting with data year 1999, race-specific estimates have been tabulated according to the 1997 Standards for Federal Data on
 
Race and Ethnicity and are not strictly comparable with estimates for earlier years. The percentage of visit records with multiple races indicated is small and lower than is typically found for
 
self-reported race in household surveys.
 
5SCHIP is State Children’s Health Insurance Program.
 
6No insurance is defined as having only self-pay, no charge, or charity as payment sources.
 
7MSA is metropolitan statistical area.
 
NOTES: The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based physicians. Estimates 
presented in this table include data from office-based physicians as defined by the American Medical Association as well as data from a sample of physicians working in CHCs. 
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Table 3. Number and percent distribution 
residence: United States, 2006 
of ambulatory care visits by setting type, according to characteristics of patient’s ZIP Code of 




















distribution Percent distribution 
All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
 Urban-rural classification1
Large  central  metro. . . . . . . . . . . . . . . . .  
Large  fringe  metro  . . . . . . . . . . . . . . . . .  
Medium  metro  . . . . . . . . . . . . . . . . . . . .  
Small  metro  . . . . . . . . . . . . . . . . . . . . .  
Nonmetropolitan. . . . . . . . . . . . . . . . . . .  
Micropolitan  . . . . . . . . . . . . . . . . . . . .  
Noncore (nonmetro) . . . . . . . . . . . . . . .  
 Median household income2 . . . . . . . . . . . .  
Quartile 1 ($0 to $32,793) . . . . . . . . . . . . .  
Quartile 2 ($32,794 to $40,626) . . . . . . . . .  
Quartile 3 ($40,627 to $52,387) . . . . . . . . .  
Quartile 4 ($52,388 and over) . . . . . . . . . .  
 Percentage with bachelor’s degree or higher3
Quartile 1 (0–12.83) . . . . . . . . . . . . . . . .  
Quartile 2 (12.84–19.66). . . . . . . . . . . . . .  
Quartile 3 (19.67–31.68). . . . . . . . . . . . . .  
Quartile 4 (31.69 and over) . . . . . . . . . . . .  
 Percentage of poverty4 . . . . . . . . . . . . . .  
Less than 5 percent . . . . . . . . . . . . . . . .  
5.00–9.99 percent. . . . . . . . . . . . . . . . . .  
10.00–19.99 percent . . . . . . . . . . . . . . . .  
20 percent or more . . . . . . . . . . . . . . . . .  
 Percentage of poverty (method 2)5 . . . . . . .  
Less than 20 percent. . . . . . . . . . . . . . . .  
20.00–29.99 percent . . . . . . . . . . . . . . . .  
30.00–39.99 percent . . . . . . . . . . . . . . . .  












































































































































































































All  visits  . . . . . . . . . . . . . . . . . . . . . . . .  
 Urban-rural classification1
Large  central  metro. . . . . . . . . . . . . . . . .  
Large  fringe  metro  . . . . . . . . . . . . . . . . .  
Medium  metro  . . . . . . . . . . . . . . . . . . . .  
Small  metro  . . . . . . . . . . . . . . . . . . . . .  
Nonmetropolitan. . . . . . . . . . . . . . . . . . .  
Micropolitan  . . . . . . . . . . . . . . . . . . . .  
Noncore (nonmetro) . . . . . . . . . . . . . . .  
 Median household income2
Quartile 1 ($0 to $32,793) . . . . . . . . . . . . .  
Quartile 2 ($32,794 to $40,626) . . . . . . . . .  
Quartile 3 ($40,627 to $52,387) . . . . . . . . .  
Quartile 4 ($52,388 and over) . . . . . . . . . .  
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1.2  1.2  
2.0  2.0  
1.3  2.4  
2.8  2.4  
4.9  3.0  
2.7  2.4  
3.3  3.0  
3.1  3.3  
2.0  1.6  
1.7  1.6  
1.5  1.6  
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Table 3. Number and percent distribution 
residence: United States, 2006—Con. 
of ambulatory care visits by setting type, according to characteristics of patient’s ZIP Code of 





















percent Standard error of percent 
 Percentage with bachelor’s degree or higher3
Quartile 1 (0–12.83) . . . . . . . . . . . . . . . .  
Quartile 2 (12.84–19.66). . . . . . . . . . . . . .  
Quartile 3 (19.67–31.68). . . . . . . . . . . . . .  
Quartile 4 (31.69 and over) . . . . . . . . . . . .  
 Percentage of poverty4
Less than 5 percent . . . . . . . . . . . . . . . .  
5.00–9.99 percent. . . . . . . . . . . . . . . . . .  
10.00–19.99 percent . . . . . . . . . . . . . . . .  
20 percent or more . . . . . . . . . . . . . . . . .  
 Percentage of poverty (method 2)5
Less than 20 percent. . . . . . . . . . . . . . . .  
20.00–29.99 percent . . . . . . . . . . . . . . . .  
30.00–39.99 percent . . . . . . . . . . . . . . . .  

















































 .  
 .  
 .  
 .  
 .  
 .  
 .  
 .  
 .  
 .  
 .  





























































* Figure does not meet standards of reliability or precision.
 
. . . Category not applicable.
 
1Excludes 5.5 percent of visits for which data were missing. For each record, county of residence was determined using patient ZIP Code and was then matched to the National Center for Health
 
Statistics’ Urban-Rural Classification Scheme for Counties described here: www.cdc.gov/nchs/r&d/rdc_urbanrural.htm.
 
2Excludes 7.4 percent of visits for which data were missing. Median household income was based on patient’s ZIP Code of residence matched to data from the 2000 census. Population quartiles
 
were estimated using U.S. Census Bureau data aggregated at the ZIP Code level.
 
3Excludes 7.9 percent of visits for which data were missing. Education level was based on patient’s ZIP Code of residence matched to data from the 2000 census. Population quartiles were
 
estimated using data aggregated at the ZIP Code level.
 
4Excludes 7.9 percent of visits for which data were missing. Poverty groupings were based on cutpoints consistent with the ‘‘Public Health Geocoding Disparities Project’’ (American Journal of
 
Epidemiology 156(5):471–82, 2002). Category 4, 20 percent or greater poverty, also corresponds to the federal designation of a high poverty area established in the 1990 census. See ‘‘Poverty
 
Areas’’, Economics and Statistics Administration, U.S. Department of Commerce, June 1995. Available from: www.census.gov/population/socdemo/statbriefs/povarea.html.
 
5Excludes 7.9 percent of visits for which data were missing. Poverty groupings were based on cutpoints consistent with the ‘‘Public Health Geocoding Disparities Project’’ (American Journal of
 
Epidemiology 156(5):471–82, 2002), but categories were further grouped to identify gradations of poverty within high-poverty areas. 
NOTES: The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based physicians. Estimates 
presented in this table include data from office-based physicians as defined by the American Medical Association as well as data from a sample of physicians working in CHCs. 
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Table 4. Number and percent distribution of 
diagnosis groups, with percent distribution 
ambulatory care visits 
by setting type: United 
with corresponding 
States, 2006 
standard errors, by the 35 leading primary 






















All  visits  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Routine infant or child health check . . . . . . . . .  V20.2  
Essential hypertension . . . . . . . . . . . . . . . . . . .  401  
Acute upper respiratory infections, excluding 
pharyngitis . . . . . . . . . . . . . . . . .  460–461,463–466 
Arthropathies and related disorders . . . . . . . .710–719 
Spinal  disorders  . . . . . . . . . . . . . . . . . . . .  720–724 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . .  250  
Specific procedures and aftercare . . . . . . .  V50–V59.9 
Malignant neoplasms . . . . . . . . . . .  140–208,230–234 
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . .V22  
Rheumatism, excluding back . . . . . . . . . . . .725–729 
Otitis media and eustachian tube disorders. . . .381–382 
Gynecological examination . . . . . . . . . . . . . . .  V72.3  
Heart disease, excluding ischemic . . . . . . .  391–392.0, 
393–398,402,404,415–416,420–429 
General medical examination . . . . . . . . . . . . . . .V70  
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . .  473  
Follow-up examination . . . . . . . . . . . . . . . . . . .V67  
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . .  789  
Asthma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  493  
Allergic  rhinitis  . . . . . . . . . . . . . . . . . . . . . . . .  477  
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . .  462  
Chronic and unspecified bronchitis . . . . . . . . .490–491 
Ischemic heart disease . . . . . . . . . . . . . .  410–414.9 
Potential health hazards related to personal and 
family  history  . . . . . . . . . . . . . . . . . . . .  V10–V19 
Sprains and strains, excluding ankle and 
back . . . . . . . . . . . . . . . . . . . .  840–844,845.1,848 
Psychoses, excluding major depressive 
disorder  . . . . . . . . .  290–295,296.0–296.1,296.4–299 
Cataract  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  366  
Contusion  with  intact  skin  surface  . . . . . . . . .920–924 
Disorders  of  lipoid  metabolism. . . . . . . . . . . . . . .  272  
Fractures, excluding lower limb . . . . . . . . . . .800–819 
Contact dermatitis and other eczema . . . . . . . . . .  692  
Benign neoplasms . . . . . . . . . . . . .  210–229,235–239 
Open wound, excluding head . . . . . . . . . . . .874–897 
Cellulitis and abscess . . . . . . . . . . . . . . . . .  681–682 
Sprains and strains of neck and back . . . . . . .  846,847 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . .  365  
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . .  
All  visits  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Routine infant or child health check . . . . . . . . .  V20.2  
Essential hypertension . . . . . . . . . . . . . . . . . . .  401  
Acute upper respiratory infections, excluding 
pharyngitis . . . . . . . . . . . . . . . . .  460–461,463–466 
Arthropathies and related disorders . . . . . . . .710–719 
Spinal  disorders  . . . . . . . . . . . . . . . . . . . .  720–724 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . .  250  
Specific procedures and aftercare . . . . . . .  V50–V59.9 
Malignant neoplasms . . . . . . . . . . .  140–208,230–234 
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . .V22  
Rheumatism, excluding back . . . . . . . . . . . .725–729 
Otitis media and eustachian tube disorders. . . .381–382 
Gynecological examination . . . . . . . . . . . . . . .  V72.3  
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Table 4. Number and percent distribution of 
diagnosis groups, with percent distribution 
ambulatory care visits 
by setting type: United 
with corresponding 
States, 2006—Con. 
standard errors, by the 35 leading primary 






















Heart disease, excluding ischemic . . . . . . .  391–392.0, 
393–398,402,404,415–416,420–429 
General medical examination . . . . . . . . . . . . . . .V70  
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . .  473  
Follow-up examination . . . . . . . . . . . . . . . . . . .V67  
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . .  789  
Asthma  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  493  
Allergic  rhinitis  . . . . . . . . . . . . . . . . . . . . . . . .  477  
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . .  462  
Chronic and unspecified bronchitis . . . . . . . . .490–491 
Ischemic heart disease . . . . . . . . . . . . . .  410–414.9 
Potential health hazards related to personal and 
family  history  . . . . . . . . . . . . . . . . . . . .  V10–V19 
Sprains and strains, excluding ankle and 
back . . . . . . . . . . . . . . . . . . . .  840–844,845.1,848 
Psychoses, excluding major depressive 
disorder  . . . . . . . . .  290–295,296.0–296.1,296.4–299 
Cataract  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  366  
Contusion  with  intact  skin  surface  . . . . . . . . .920–924 
Disorders  of  lipoid  metabolism. . . . . . . . . . . . . . .  272  
Fractures, excluding lower limb . . . . . . . . . . .800–819 
Contact dermatitis and other eczema . . . . . . . . . .  692  
Benign neoplasms . . . . . . . . . . . . .  210–229,235–239 
Open wound, excluding head . . . . . . . . . . . .874–897 
Cellulitis and abscess . . . . . . . . . . . . . . . . .  681–682 
Sprains and strains of neck and back . . . . . . .  846,847 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . .  365  
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* Figure does not meet standards of reliability or precision. 
– Quantity zero. 
0.0 Quantity more than zero but less than 0.05.
 
. . . Category not applicable.
 
1Based on the  International Classification of Diseases, Ninth Revision, Clinical Modification. However, certain codes have been combined in this table to form larger categories that better describe
 
the utilization of ambulatory care services.
 
NOTES: The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based physicians. Estimates 
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Table 5. Annual number and percent distribution of ambulatory care visits by setting type, according to diagnosis group: United States, 2005–2006 































































































































































Streptococcal sore throat . . . . . . . . . . . . . . . . . . .
 
 
Human immunodeficiency virus syndrome
 
 
(HIV) . . . . .






Unspecified viral and chlamydial infections . . . . . . . .
 
 
















































Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Malignant neoplasms of colon and rectum . . . . . . . .
Malignant neoplasm of skin. . . . . . . . . . . . . . . . . .
Malignant neoplasm of breast . . . . . . . . . . . . . . . .
Malignant neoplasm of prostate . . . . . . . . . . . . . . .
Malignant neoplasm of lymphatic and hematopoietic
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other malignant neoplasms . . . . . . . . . . . . . . . . .
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . .
Other benign neoplasm . . . . . . . . . . . . . . . . . . . .
Neoplasm of uncertain behavior and unspecified
nature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Endocrine, nutritional and metabolic diseases, and
immunity disorders. . . . . . . . . . . . . . . . . . . . . . . .
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . .
Other disorders of thyroid gland . . . . . . . . . . . . . . .
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . .
Disorders of lipoid metabolism . . . . . . . . . . . . . . . .
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other endocrine, nutritional and metabolic diseases,
and immunity disorders . . . . . . . . . . . . . . . . . . .
Diseases of the blood and blood-forming organs . . . . . .
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other diseases of the blood and blood-forming
organs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . .
Schizophrenic disorders . . . . . . . . . . . . . . . . . . . .
Major depressive disorder . . . . . . . . . . . . . . . . . .
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . .
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . .
Neurotic depression . . . . . . . . . . . . . . . . . . . . . .
Alcohol dependence syndrome . . . . . . . . . . . . . . .
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Table 5. Annual  number and percent distribution of ambulatory care visits by setting type, according to diagnosis group: United States, 2005–2006—Con.  
Primary  Surgical  Medical  Hospital  Hospital  Primary  Surgical  Medical  Hospital  Hospital  
care  specialty  specialty  outpatient  emergency  Combined  care  specialty  specialty  outpatient  emergency  
Diagnosis  group  Combined  settings  offices  offices  offices  departments  departments  settings  offices  offices  offices  departments  departments
 Drug dependence  and  nondependent  abuse  of 
 
 drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,409  0.2  760  *  *  513  1,024  100.0  31.6  *0.2  *4.4  21.3  42.5 
 
 Acute  reaction  to stress  and  adjustment  reaction  . . . .  3,003  0.3  789  –  1,632  502  80  100.0  26.3  .  .  .  54.3  16.7  2.7 
 
 Depressive  disorder,  not elsewhere classified  .  .  . . . .  7,716  0.7  4,284  *  1,967  891  548  100.0  55.5  *0.3  25.5  11.5  7.1 
 
Attention deficit disorder. . . . . . . . . . . . . . . . . . . .  6,977  0.6  3,529  –  2,630  794  *  100.0  50.6  . . .  37.7  11.4  *0.3 
 
 Other mental disorders . . . . . . . . . . . . . . . . . . . . 4,886  0.4  1,397  *  2,282  557  446  100.0  28.6  4.2  46.7  11.4  9.1 
 
 Diseases  of  the  nervous  system  and sense  organs  . . . .  97,381  8.5  28,530  48,437  8,452  6,138  5,823  100.0  29.3  49.7  8.7  6.3  6.0 
 
 Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,163  0.5  2,684  *809  1,155  308  1,209  100.0  43.5  *13.1  18.7  5.0  19.6 
 
 Other  disorders  of  the  central  nervous system  . . . . . .  6,662  0.6  1,405  611  3,579  752  314  100.0  21.1  9.2  53.7  11.3  4.7 
 
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . .  2,277  0.2  *  1,065  499  176  *  100.0  22.4  46.8  21.9  7.7  *1.2 
 
 Other  disorders  of  the  peripheral  nervous system  . . . .  3,753  0.3  1,478  545  1,300  261  168  100.0  39.4  14.5  34.6  7.0  4.5 
 
 Retinal  detachment  and  other  retinal disorders. . . . . .  4,564  0.4  *  4,112  *  168  *  100.0  *6.0  90.1  *0.1  *3.7  *0.1 
 
 Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,980  0.8  *  8,708  –  252  *  100.0  *0.2  97.0  . . .  2.8  *0.0 
 
 Cataract . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . 9,933  0.9  *  9,474  –  260  *  100.0  *2.0  95.4  . . .  2.6  *0.0 
 
 Disorders  of  refraction  and  accommodation. . . . . . . . 4,739  0.4  *  4,226  *  246  *  100.0  *2.2  89.2  *3.3  5.2  *0.1 
 
 Conjunctivitis . . . . . . . . . . . . . .  . . . . . . . . . . . . 5,246  0.5  3,084  892  *  443  635  100.0  58.8  17.0  *3.7  8.5  12.1 
 
 Disorders of eyelids . . . . . . . . . . . . .  . . . . . . . . . 3,406  0.3  *  2,185  *  190  155  100.0  19.6  64.2  *6.1  5.6  4.6 
 
 Other  disorders  of  the  eye  and  adnexa  . . . . . . . . . .  12,332 1.1  929  9,554  *722  673  454  100.0  7.5  77.5  *5.9  5.5  3.7 
 
 Disorders of external ear  . . . . . . . . . . . . . . . . . . .  5,067 0.4  2,548  1,483  *  419  422  100.0  50.3  29.3  *3.9  8.3  8.3 
 
 Otitis  media  and  eustachian  tube  disorders  . . . . . . . .  17,779 1.6  11,836  2,067  *  1,616  2,072  100.0  66.6  11.6  *1.1  9.1  11.7 
 
 Other  disorders  of  the  ear  and  mastoid  process  . . . . .  6,480 0.6  2,796  2,706  *  375  353  100.0  43.1  41.8  *3.9  5.8  5.4 
 
 Diseases  of  the  circulatory  system. . . . . . . . . . . . . . .  87,884  7.7 47,767  6,729  22,497  6,684  4,207  100.0  54.4  7.7  25.6  7.6  4.8 
 
 Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . .  1,060  0.1 *  *  562  *  53  100.0  37.8  *1.5  53.0  *2.7  5.0 
 
 Coronary  atherosclerosis  . . . . . . . . . . . . . . . . . . .  8,704  0.8 2,860  *  4,943  395  51  100.0  32.9  *5.2  56.8  4.5  0.6 
 
 Other ischemic heart disease  . . . . . . . . . . . . . . . .  1,607  0.1  * –  726  93  536  100.0  15.7  . . .  45.2  5.8  33.3 
 
 Cardiac  dysrhythmias . . . . . . . . . . . .   . . . . . . . . . 6,609  0.6  2,525 *  2,646  669  683  100.0  38.2  *1.3  40.0  10.1  10.3 
 
 Congestive  heart  failure . . . . . . . . . . . .   . . . . . . . . 3,390  0.3  1,443 *  1,037  230  658  100.0  42.6  *0.6  30.6  6.8  19.4 
 
 Other heart disease . . . . . . . . . . . . .   . . . . . . . . . 5,234  0.5  1,502 *  3,052  *407  188  100.0  28.7  *1.6  58.3  *7.8  3.6 
 
 Essential  hypertension. . . . . . . . . . . . . . . . . . . . .  44,879  3.9  34,421  * 5,638  3,891  761  100.0  76.7  *0.4  12.6  8.7  1.7 
 
 Cerebrovascular  disease  .  .  . . . . . . . . . . . . . . . . .  3,982  0.3  1,101  *1,371 670  211  628  100.0  27.7  *34.4  16.8  5.3  15.8 
 
 Diseases  of  the  arteries,  arterioles  and   capillaries . . . .  3,737  0.3  *  *2,015 813  221  93  100.0  *15.9  53.9  *21.8  *5.9  *2.5 
 
 Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,704  0.2  802  *930 *  137  139  100.0  29.7  *34.4  *25.7  5.1  5.1 
 
 Other  diseases  of  the  circulatory  system  . . . . . . . . .  5,979  0.5  1,865  *1,580  *1,715 400  419  100.0  31.2  26.4  28.7  6.7  7.0 
 
 Diseases  of  the  respiratory  system  . . . . . . . . . . . . . .  130,428  11.4  86,138  6,342  15,003 10,602  12,342  100.0  66.0  4.9  11.5  8.1  9.5 
 
 Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . .  4,820  0.4  3,379  246  * 539  212  100.0  70.1  5.1  *9.2  11.2  4.4 
 
 Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . .  13,213  1.2  10,088  *  * 1,289  1,677  100.0  76.3  *0.5  *0.7  9.8  12.7 
 
 Acute tonsillitis . . . . . . . . . . . . . .   . . . . . . . . . . . 2,299  0.2  1,622  *  *  *173 280  100.0  70.5  *7.4  *2.4  *7.5  12.2 
 
 Acute  bronchitis  and  bronchiolitis  . . . . . . . . . . . . . .  5,869  0.5  4,123  *  *  455 898  100.0  70.2  *0.2  *6.5  7.7  15.3 
 
 Other  acute  respiratory  infections  . . . . . . . . . . . . . .  28,322  2.5  21,734  236  *1,243  2,516 2,594  100.0  76.7  0.8  *4.4  8.9  9.2 
 
 Chronic sinusitis . . . . . . . . . . . . .   . . . . . . . . . . . 14,718  1.3  10,990  1,170  *  1,327 595  100.0  74.7  8.0  4.3  9.0  4.0 
 
 Allergic rhinitis. . . . . . . . . . . . . . . . . . . . . . . . . .  12,488  1.1  6,031  *1,625  *3,932  798  101 100.0  48.3  *13.0  *31.5  6.4  0.8 
 
 Pneumonia. . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,242  0.4  2,250  –  *  298  1,500 100.0  53.0  . . .  *4.6  7.0  35.4 
 
 Chronic  and  unspecified  bronchitis  . . . . . . . . . . . . .  11,619  1.0  8,194  *  732  982  1,615 100.0  70.5  *0.8  6.3  8.4  13.9 
 
 Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14,586  1.3  8,115  *  *3,564  1,198  1,681 100.0  55.6  *0.2  24.4  8.2  11.5 
 













ugust 6, 2008 
Table 5. Annual  number and percent distribution of ambulatory care visits by setting type, according to diagnosis group: United States, 2005–2006—Con.  
Primary  Surgical  Medical  Hospital  Hospital  Primary  Surgical  Medical  Hospital  Hospital  
care  specialty  specialty  outpatient  emergency  Combined  care  specialty  specialty  outpatient  emergency
Diagnosis  group  Combined  settings  offices  offices  offices  departments  departments  settings  offices  offices  offices  departments  department
 Other  chronic obstructive  pulmonary  disease  and 
 
allied conditions . . . . . . . . . . . . . . . . . . . . . . . .  7,498  0.7  4,581  *  2,318  325  205  100.0  61.1  *0.9  30.9  4.3  2.7 
 
 Other  diseases  of  the respiratory system  .  .  .  .  . . . . .  10,752  0.9  5,031  2,618  1,417  703  984  100.0  46.8  24.3  13.2  6.5  9.1 
 
 Diseases  of  the  digestive system . . . . . . . . . . . . . . .  42,247  3.7  16,990  6,307  8,985  2,870  7,094  100.0  40.2  14.9  21.3  6.8  16.8 
 
 Diseases  of  the  teeth  and supporting  structures  .  .  .  .  .  3,183  0.3  1,139  *199  *  254  1,566  100.0  35.8  *6.3  *0.8  8.0  49.2 
 
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . .  2,835  0.2  1,172  *  *  192  490  100.0  41.4  *6.3  *28.2  6.8  17.3 
 
 Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . .  *561  *0.0  *  *  *  *  54  100.0  49.7  *11.4  *25.5  *3.8  *9.5 
 
Ulcer  of  stomach  and  small  intestine  . . . . . . . . . . . .  *741  *0.1  *  *  *  *  66  100.0  *30.6  *3.5  *52.4  *4.6  *8.9 
 
 Hernia  of  abdominal  cavity  . . . . . . . . . . . . . . . . . .  3,510  0.3  774  2,023  *  270  257  100.0  22.1  57.6  *5.3  7.7  7.3 
 
Noninfectious  enteritis   and  colitis . . . . . . . . . . . . . .  5,704  0.5  2,943  *  895  352  1,403  100.0  51.6  *1.9  15.7  6.2  24.6 
 
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . .  2,042  0.2  778  360  *  *51  206  100.0  38.1  17.7  31.6  *2.5  10.1 
 
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,841  0.2  1,316  *  *  271  481  100.0  46.3  *3.8  23.4  9.5  16.9 
 
 Irritable bowel syndrome . . . . . . . . . . . . . . . . . . .  995  0.1  *  *  *  82  *  100.0  44.2  *0.5  45.2  *8.3  *1.9 
 
 Anal and rectal diseases  . . . . . . . . . . . . . . . . . . . 2,128  0.2  794  *572  *  107  211  100.0  37.3  26.9  *20.9  5.0  9.9 
 
 Disorders  of  the  gallbladder  and  biliary  tract  . . . . . . . 2,051  0.2  *  1,196  *  114  295  100.0  17.5  58.3  *4.2  5.6  14.4 
 
 Gastrointestinal  hemorrhage  . . . . . . . . . . . . . . . . . 998  0.1  *  *  *  *57  419  100.0  29.1  *3.6  *19.6  *5.7  42.0 
 
 Other  diseases  of  the  digestive  system  . . . . . . . . . . 14,657  1.3  6,478  1,428  4,062  1,063  1,626  100.0  44.2  9.7  27.7  7.3  11.1 
 
 Diseases  of  the  genitourinary  system  . . . . . . . . . . . . .  50,108 4.4  25,744  11,690  2,896  4,228  5,551  100.0  51.4  23.3  5.8  8.4  11.1 
 
 Calculus  of  kidney  and  ureter  .  .  .  .  .  .  . . . . . . . . . .  2,431 0.2  *  1,274  *  158  567  100.0  16.9  52.4  *0.9  6.5  23.3 
 
 Cystitis  and  other  disorders  of  the  bladder  . . . . . . . .  2,180 0.2  954  891  *  130  188  100.0  43.8  40.9  *0.8  6.0  8.6 
 
 Urinary  tract  infection,  site  not  specified  . . . . . . . . . .  8,149  0.7 4,276  851  *  816  1,926  100.0  52.5  10.4  *3.4  10.0  23.6 
 
 Other  diseases  of  the  urinary  system. . . . . . . . . . . .  7,234  0.6 2,019  2,011  1,748  586  870  100.0  27.9  27.8  24.2  8.1  12.0 
 
  Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . .  2,904  0.3 *  2,091  *  105  *  100.0  21.8  72.0  *2.1  3.6  *0.4 
 
 Other  disorders  of  male  genital  organs. . . . . . . . . . .  3,513  0.3 1,055  1,730  *  309  268  100.0  30.0  49.2  *4.3  8.8  7.6 
 
  Disorders of the breast . . . . . . . . . . . . . . . . . . . .  4,889  0.4  1,717 2,333  *  482  138  100.0  35.1  47.7  *4.5  9.9  2.8 
 
 Inflammatory  disorders  of  female  pelvic  organs  . . . . .  3,190  0.3  2,486 *  *  269  410  100.0  77.9  *0.4  *0.4  8.4  12.8 
 
 Noninflammatory  disorders  of  female  genital  organs  .  .  3,422  0.3  2,379 *  *  318  520  100.0  69.5  3.8  *2.3  9.3  15.2 
 
 Disorders  of  menstruation  and  abnormal   bleeding . . . .  4,080  0.4  3,382 –  *  397  212  100.0  82.9  .  .  .  *2.2  9.7  5.2 
 
 Menopausal  and  postmenopausal  disorders  . . . . . . .  2,333  0.2  2,218  * –  90  *  100.0  95.1  *0.9  .  .  .  3.9  *0.1 
 
 Other  disorders  of  the  female  genital  tract. . . . . . . . .  5,782  0.5  4,214  345 *  568  436  100.0  72.9  6.0  *3.8  9.8  7.5 
 
 Complications  of  pregnancy,  childbirth,  and  the
  puerperium . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8,093  0.7  5,241  *  * 1,353  1,407  100.0  64.8  *0.1  *1.0  16.7  17.4  
 Diseases  of  the  skin  and  subcutaneous  tissue  . . . . . . .  48,589  4.2  19,541  3,650  17,748 3,145  4,506  100.0  40.2  7.5  36.5  6.5  9.3 
 
  Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . .  8,036  0.7  3,980  374  * 626  2,649  100.0  49.5  4.7  5.1  7.8  33.0 
 
 Other  infection  of  the  skin  and  subcutaneous  tissue  .  .  2,393  0.2  1,283  232  * 217 358  100.0  53.6  9.7  12.7  9.1  15.0 
 
 Contact  dermatitis  and  other  eczema. . . . . . . . . . . .  9,343  0.8  5,428  *  2,575  597 550  100.0  58.1  *2.1  27.6  6.4  5.9 
 
Psoriasis  and  similar   disorders. . . . . . . . . . . . . . . .  1,591  0.1  *  *  1,158  126 *  100.0  *16.5  *0.7  72.8  7.9  *2.1 
 
 Other  inflammatory  conditions  of  skin 
 and
  subcutaneous tissue . . . . . . . . . . . . . . . . . . . . .  4,809  0.4  1,657  *  2,377  346 215  100.0  34.5  *4.4  49.4  7.2 
 4.5 
 
 Corns,  callosities,  and  other  hypertrophic 
 and
 atrophic  skin  conditions  . . . . . . . . . . . . . . . . . . .  2,098  0.2  679  *629  647  129  * 100.0  32.3  30.0  30.8  6.2  *0.7 
 
 Actinic  and  seborrheic  keratosis  . . . . . . . . . . . . . . .  4,525  0.4  *  *  3,773  *  * 100.0  12.7  *2.1  83.4  *1.8  *0.0 
 
 Acne. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,279  0.4  1,143  *  2,956  *120  * 100.0  26.7  *1.1  69.1  *2.8  *0.3 
 
 Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . .  2,133  0.2  909  577  450  125  72 100.0 42.6  27.0  21.1  5.9  3.4 
 
 Urticaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,517  0.1  *  –  *  138  288  100.0 40.5 . . .  31.4  9.1  19.0 
 
 Other  disorders  of  the  skin  and  subcutaneous  tissue  .  .  7,865  0.7  3,010  1,281  2,626  638  311  100.0 38.3 16.3  33.4  8.1  3.9 
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Other arthropathies and related
 
 





















Intervertebral disc disorders . . . . . . . . . . . . . . . . .
 









Other dorsopathies . . . . . . . . . . . . . . . . . . . . . . .
 
 























































Other rheumatism, excluding back . . . . . . . . . . . . .
Disorders of bone and cartilage . . . . . . . . . . . . . . .
Other diseases of the musculoskeletal system and
connective tissue . . . . . . . . . . . . . . . . . . . . . . .
Congenital anomalies. . . . . . . . . . . . . . . . . . . . . . .
Certain conditions originating in the perinatal period . . . .
Symptoms, signs, and ill-defined conditions . . . . . . . . .
Syncope and collapse . . . . . . . . . . . . . . . . . . . . .
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dizziness and giddiness. . . . . . . . . . . . . . . . . . . .
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . .
Symptoms involving skin and other integumentary
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . .
Dyspnea and respiratory abnormalities. . . . . . . . . . .
Cough. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Symptoms involving the urinary system . . . . . . . . . .
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . .
Other symptoms, signs, and ill-defined conditions . . . .
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . .
Fracture of radius and ulna . . . . . . . . . . . . . . . . . .
Fracture of hand and fingers . . . . . . . . . . . . . . . . .
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . .
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . .
Sprains and strains of wrist and hand . . . . . . . . . . .
Sprains and strains of knee and leg . . . . . . . . . . . .
Sprains and strains of ankle . . . . . . . . . . . . . . . . .
Sprains and strains of neck. . . . . . . . . . . . . . . . . .
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Table 5. Annual number and percent distribution of ambulatory care visits by setting type, according to diagnosis group: United States, 2005–2006—Con.                     
Primary  Surgical  Medical  Hospital  Hospital  Primary  Surgical  Medical  Hospital  Hospital  
care  specialty  specialty  outpatient  emergency  Combined  care  specialty  specialty  outpatient  emergency  
Diagnosis  group  Combined  settings  offices  offices  offices  departments  departments  settings  offices  offices  offices  departments  departments
  Other sprains and strains of back . . . . . . . . . . . . . .    5,509  0.5  2,569  *  *861  265  1,252  100.0  46.6  10.2  *15.6  4.8  22.7 
 
   Other sprains and strains . . . . . . . . . . . . . . . . . . .  6,139  0.5  1,973  1,741  *  387  1,511  100.0  32.1  28.4  *8.6  6.3  24.6 
 
  Intracranial injury, excluding those with skull fracture . .       623  0.1  *  *  *  *  277  100.0  34.6  *7.8  *11.7  *1.4  44.5 
 
 Open wound of head . . . . . . . . . . . . . . . . . . . . .  3,318  0.3  *  *  *  155  2,096  100.0  17.0  13.0  *2.1  4.7  63.2 
 
     Open wound of hand and fingers . . . . . . . . . . . . . .  3,480  0.3  *  *  *  246  1,725  100.0  19.4  14.5  *9.5  7.1  49.6 
 
Other open wound . . . . . . . . . . . . . . . . . . . . . . .  5,065  0.4  1,636  411  *  530  2,365  100.0  32.3  8.1  *2.4  10.5  46.7 
 
Superficial injury of cornea . . . . . . . . . . . . . . . . . .  854  0.1  *  *  *  *49  331  100.0  *14.8  37.0  *3.6  *5.8  38.7 
 
  Other superficial injury. . . . . . . . . . . . . . . . . . . . .  3,498  0.3  1,636  *  *  235  1,196  100.0  46.8  *4.4  *7.8  6.7  34.2 
 
    Contusion with intact skin surface. . . . . . . . . . . . . .  9,920  0.9  2,998  604  *  643  5,091  100.0  30.2  6.1  *5.9  6.5  51.3 
 
 Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . .  10,734  0.9  3,165  2,552  *587  796  3,634  100.0  29.5  23.8  *5.5  7.4  33.9 
 
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,613  0.1  *  *  *  *69  914  100.0  27.9  *1.8  *9.4  *4.3  56.6 
 
       Other and unspecified effects of external causes . . . .   3,561  0.3  1,695  *  *  227  1,061  100.0  47.6  *8.8  *7.5  6.4  29.8 
 
      
 Complications of surgical and medical care, not
  elsewhere classified . . . . . . . . . . . . . . . . . . . . . 2,308  0.2  *  907  *  157  464  100.0  *28.7  39.3  *5.1  6.8  20.1 
 
      Supplementary classification of factors influencing health
       status and contact with health services . . . . . . . . . . . 203,441 17.7  126,168  35,423  18,887  19,702  3,261  100.0  62.0  17.4  9.3  9.7  1.6  
      Potential health hazards related to communicable
  diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,791 0.5  3,596  *  *  1,778  122  100.0  62.1  *1.3  *3.8  30.7  2.1  
       Potential health hazards related to personal and
  family history . . . . . . . . . . . . . . . . . . . . . . . . .  10,890 0.9  4,203  2,359  2,842  1,249  237  100.0  38.6  21.7  26.1  11.5  2.2  
      Routine infant or child health check. . . . . . . . . . . . .  44,265 3.9  40,437  *  *  3,632  77  100.0  91.4  *0.1  *0.2  8.2  0.2  
  Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . .  20,723  1.8 17,492  –  *  2,870  234  100.0  84.4  . . .  *0.6  13.8  1.1  
    Postpartum care and examination. . . . . . . . . . . . . .  2,328  0.2 1,958  *  *  273  *  100.0  84.1  *3.5  *0.6  11.7  *0.0  
     Encounter for contraceptive management . . . . . . . . .  3,240  0.3 2,344  386  *  496  *  100.0  72.3  11.9  *0.0  15.3  *0.4  
      Other encounter related to reproduction . . . . . . . . . .  1,792  0.2 1,091  *  *  543  *  100.0  60.9  *3.7  *3.7  30.3  *1.4  
  Lens replaced by pseudophakos . . . . . . . . . . . . . .  *1,579  0.1  – *1,552  –  *  –  100.0  . . .  98.3  . . .  *1.7  . . .  
        Artificial opening status and other postsurgical states. .  8,799  0.8  1,187 6,309  641  593  68  100.0  13.5  71.7  7.3  6.7  0.8  
       Attention to surgical dressings and sutures . . . . . . . .  2,220  0.2  832 503  *  215  534  100.0  37.5  22.7  *6.1  9.7  24.1  
      Follow-up examination. . . . . . . . . . . . . . . . . . . . .  16,027  1.4  4,502  8,482 1,979  954  111  100.0  28.1  52.9  12.3  6.0  0.7  
    General medical examination . . . . . . . . . . . . . . . .  16,594  1.4  12,859  *717 *1,724  1,059  234  100.0  77.5  *4.3  *10.4  6.4  1.4  
      Observation and evaluation for suspected conditions
 not found . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,703  0.6  2,840  1,251 1,338  761  512  100.0  42.4  18.7  20.0  11.4  7.6  
   Gynecological examination . . . . . . . . . . . . . . . . . .  16,592  1.4  15,257  –  * 1,240  *  100.0  92.0  . . .   *0.6  7.5  *0.0  
        Other factors influencing health status and contact with
  health services. . . . . . . . . . . . . . . . . . . . . . . . .  45,898  4.0  17,569  13,599  9,630 4,011  1,090  100.0  38.3  29.6  21.0  8.7  2.4  
   Blank and illegible . . . . . . . . . . . . . . . . . . . . . . . . .  22,593  2.0  10,865  2,687  3,783 1,340  3,920  100.0  48.1  11.9  16.7  5.9  17.4 
 
          * Figure does not meet standards of reliability or precision.
   – Quantity zero.
   . . . Category not applicable.
         0.0 Quantity more than zero but less than 0.05.
                         NOTES: Numbers may not add to totals because of rounding. Figures are annual averages. The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based            
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 All ambulatory care settings . . . . . . .
 
 
Primary care offices. . . . . . . . . . . .
 







Surgical specialty offices . . . . . . . . .
Hospital outpatient departments . . . .




































































































































































































 1Visits at which one or more drugs were provided, prescribed, or
 








 2Number of drugs provided, prescribed, or continued at visits (up to eight per visit).




 of drug visits divided by total number of all visits multiplied by 100). 
 
 





NOTES: Numbers may not add to totals because of rounding. The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to
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Table 7. 
percent 
Number and rate of occurrences 
distribution by setting type, with 
of the 20 most 
corresponding 
frequently prescribed drug therapeutic 
standard errors: United States, 2006 
classes at ambulatory care visits and 























All occurrences . . . . . . . . . . . . . . . . . . .  
Analgesics . . . . . . . . . . . . . . . . . . . . . .  
Antihyperlipidemic agents . . . . . . . . . . . . .  
Antidepressants . . . . . . . . . . . . . . . . . . .  
Anxiolytics, sedatives, and hypnotics . . . . . .  
Antidiabetic agents . . . . . . . . . . . . . . . . .  
Bronchodilators . . . . . . . . . . . . . . . . . . .  
Antiplatelet agents . . . . . . . . . . . . . . . . .  
Beta-adrenergic blocking agents . . . . . . . . .  
Proton  pump  inhibitors  . . . . . . . . . . . . . . .  
Antihistamines  . . . . . . . . . . . . . . . . . . . .  
Dermatological agents . . . . . . . . . . . . . . .  
Diuretics  . . . . . . . . . . . . . . . . . . . . . . .  
Anticonvulsants . . . . . . . . . . . . . . . . . . .  
Angiotensin converting enzyme inhibitors . . . 
Adrenal cortical steroids . . . . . . . . . . . . . .  
Ophthalmic preparations. . . . . . . . . . . . . .  
Antiemetic/antivertigo agents . . . . . . . . . . .  
Penicillins . . . . . . . . . . . . . . . . . . . . . . .  
Calcium channel blocking agents . . . . . . . .  




























































































































































All occurences . . . . . . . . . . . . . . . . . . . .  
Analgesics . . . . . . . . . . . . . . . . . . . . . .  
Antihyperlipidemic agents . . . . . . . . . . . . .  
Antidepressants . . . . . . . . . . . . . . . . . . .  
Anxiolytics, sedatives, and hypnotics . . . . . .  
Antidiabetic agents . . . . . . . . . . . . . . . . .  
Bronchodilators . . . . . . . . . . . . . . . . . . .  
Antiplatelet agents . . . . . . . . . . . . . . . . .  
Beta-adrenergic blocking agents . . . . . . . . .  
Proton  pump  inhibitors  . . . . . . . . . . . . . . .  
Antihistamines  . . . . . . . . . . . . . . . . . . . .  
Dermatological agents . . . . . . . . . . . . . . .  
Diuretics  . . . . . . . . . . . . . . . . . . . . . . .  
Anticonvulsants . . . . . . . . . . . . . . . . . . .  
Angiotensin converting enzyme inhibitors . . . 
Adrenal cortical steroids . . . . . . . . . . . . . .  
Ophthalmic preparations. . . . . . . . . . . . . .  
Antiemetic/antivertigo agents . . . . . . . . . . .  
Penicillins . . . . . . . . . . . . . . . . . . . . . . .  
Calcium channel blocking agents . . . . . . . .  
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0.8  1.5  
0.9  1.3  
1.1  2.5  
0.8  2.6  
0.8  2.4  
1.0  2.1  
0.6  4.5  
1.1  3.1  
1.2  2.3  
1.0  3.7  
0.7  1.9  
1.0  3.5  
0.9  3.1  
1.6  2.5  
0.9 2.2 
2.2  3.4  
5.1  1.5  
0.6  1.8  
0.7  0.5  
1.2  3.8  











































. . .Category not applicable.
 
1Based on Multum Lexicon second-level therapeutic drug category (see www.multum.com/Lexicon.htm).
 
2Total of all therapeutic drug categories will exceed total number of drug mentions because up to four categories may be coded for each drug.
 
3Based on an estimated 2,356,882,000 drug mentions at ambulatory care visits in 2006. A drug mention is defined as any medication that is provided, prescribed, or continued at the visit, including
 
over-the-counter preparations, immunizations, desensitizing agents, and anesthetics.
 
NOTE: Numbers may not add to totals because of rounding. The 2006 National Ambulatory Medical Care Survey included a sample of community health centers (CHCs) in addition to the
 
traditional sample of office-based physicians. Estimates presented in this table include data from office-based physicians as defined by the American Medical Association as well as data from a
 
sample of physicians working in CHCs.
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Table 8. 
percent 
Annual number and rate of therapeutic categories 
distribution by setting type: United States, 2006 
for drugs provided, prescribed, or continued at ambulatory care visits and 























All occurrences . . . . . . . . . . . . . . . . . . . . . .  
Anti-infectives. . . . . . . . . . . . . . . . . . . . . . .  
Amebicides  . . . . . . . . . . . . . . . . . . . . . . .  
Antifungals . . . . . . . . . . . . . . . . . . . . . . .  
Azole antifungals . . . . . . . . . . . . . . . . . .  
Miscellaneous antifungals . . . . . . . . . . . .  
Antimalarial agents . . . . . . . . . . . . . . . . . .  
Antimalarial  quinolines  . . . . . . . . . . . . . .  
Miscellaneous antimalarials . . . . . . . . . . .  
Antituberculosis agents . . . . . . . . . . . . . . .  
Nicotinic  acid  derivatives  . . . . . . . . . . . . .  
Rifamycin  derivatives  . . . . . . . . . . . . . . .  
Antiviral agents . . . . . . . . . . . . . . . . . . . .  
Protease inhibitors . . . . . . . . . . . . . . . . .  
NRTIs. . . . . . . . . . . . . . . . . . . . . . . . .  
NNRTIs. . . . . . . . . . . . . . . . . . . . . . . .  
Adamantane  antivirals. . . . . . . . . . . . . . .  
Purine nucleosides. . . . . . . . . . . . . . . . .  
Neuraminidase inhibitors . . . . . . . . . . . . .  
Antiviral  combinations  . . . . . . . . . . . . . . .  
Cephalosporins . . . . . . . . . . . . . . . . . . . .  
First generation cephalosporins . . . . . . . . .  
Second generation cephalosporins . . . . . . .  
Third generation cephalosporins . . . . . . . .  
Fourth generation cephalosporins. . . . . . . .  
Leprostatics . . . . . . . . . . . . . . . . . . . . . .  
Macrolide  derivatives  . . . . . . . . . . . . . . . . .  
Macrolides  . . . . . . . . . . . . . . . . . . . . . .  
Ketolides  . . . . . . . . . . . . . . . . . . . . . . .  
Miscellaneous antibiotics . . . . . . . . . . . . . .  
Penicillins . . . . . . . . . . . . . . . . . . . . . . . .  
Penicillinase resistant penicillins . . . . . . . .  
Aminopenicillins . . . . . . . . . . . . . . . . . .  
Beta-lactamase  inhibitors  . . . . . . . . . . . . .  
Natural penicillins . . . . . . . . . . . . . . . . .  
Quinolones . . . . . . . . . . . . . . . . . . . . .  
Sulfonamides . . . . . . . . . . . . . . . . . . . .  
Tetracyclines . . . . . . . . . . . . . . . . . . . .  
Urinary  anti-infectives  . . . . . . . . . . . . . . .  
Aminoglycosides . . . . . . . . . . . . . . . . . .  
Lincomycin derivatives . . . . . . . . . . . . . .  
Antineoplastics. . . . . . . . . . . . . . . . . . . . .  
Alkylating agents . . . . . . . . . . . . . . . . . .  
Antibiotics/antineoplastics . . . . . . . . . . . .  
Antimetabolites  . . . . . . . . . . . . . . . . . . .  
Hormones/antineoplastics . . . . . . . . . . . .  
Miscellaneous antineoplastics . . . . . . . . . .  
Mitotic  inhibitors  . . . . . . . . . . . . . . . . . .  
Antineoplastic monoclonal antibodies . . . . .  
Tyrosine kinase inhibitors . . . . . . . . . . . . .  
Biologicals  . . . . . . . . . . . . . . . . . . . . . . .  
Colony  stimulating  factors  . . . . . . . . . . . .  
Recombinant human erythropoietins . . . . . .  
Cardiovascular agents . . . . . . . . . . . . . . . .  
Angiotensin converting enzyme 
inhibitors  . . . . . . . . . . . . . . . . . . . . . .  
Antiadrenergic agents, peripherally 
acting  . . . . . . . . . . . . . . . . . . . . . . . .  
Antiadrenergic agents, centrally acting. . . . .  
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Table 8. 
percent 
Annual number and rate of therapeutic categories for drugs 
distribution by setting type: United States, 2006—Con. 
provided, prescribed, or continued at ambulatory care visits and 























Antianginal agents . . . . . . . . . . . . . . . . .  
Antiarrhythmic agents . . . . . . . . . . . . . . .  
Beta-adrenergic blocking agents . . . . . . . .  
Cardioselective beta blockers . . . . . . . . .  
Noncardioselective beta blockers . . . . . .  
Calcium channel blocking agents . . . . . . . .  
Diuretics  . . . . . . . . . . . . . . . . . . . . . . .  
Loop diuretics . . . . . . . . . . . . . . . . . .  
Potassium-sparing diuretics . . . . . . . . . .  
Thiazide  diuretics  . . . . . . . . . . . . . . . .  
Carbonic anhydrase inhibitors . . . . . . . .  
Inotropic agents . . . . . . . . . . . . . . . . . .  
Miscellaneous cardiovascular agents . . . . .  
Vasodilators . . . . . . . . . . . . . . . . . . . . .  
Vasopressors . . . . . . . . . . . . . . . . . . . .  
Antihypertensive combinations . . . . . . . . .  
Angiotensin II inhibitors . . . . . . . . . . . . . .  
Agents for pulmonary hypertension. . . . . . .  
Aldosterone receptor antagonists . . . . . . . .  
Central nervous system agents . . . . . . . . . .  
Analgesics . . . . . . . . . . . . . . . . . . . . . .  
Miscellaneous analgesics . . . . . . . . . . .  
Narcotic analgesics . . . . . . . . . . . . . . .  
Nonsteroidal anti-inflammatory agents . . . 
Salicylates  . . . . . . . . . . . . . . . . . . . .  
Analgesic combinations . . . . . . . . . . . .  
Narcotic analgesic combinations . . . . . . .  
Antimigraine agents . . . . . . . . . . . . . . .  
Cox-2  inhibitors  . . . . . . . . . . . . . . . . .  
Anticonvulsants . . . . . . . . . . . . . . . . . . .  
Hydantoin anticonvulsants . . . . . . . . . . .  
Barbiturate anticonvulsants . . . . . . . . . .  
Benzodiazepine anticonvulsants . . . . . . .  
Miscellaneous anticonvulsants . . . . . . . .  
Dibenzazepine anticonvulsants . . . . . . . .  
Antiemetic/antivertigo agents . . . . . . . . . .  
5HT3 receptor antagonists . . . . . . . . . .  
Phenothiazine antiemetics . . . . . . . . . . .  
Anticholinergic  antiemetics  . . . . . . . . . .  
Miscellaneous antiemetics . . . . . . . . . . .  
Anti-Parkinson agents . . . . . . . . . . . . . . .  
Anticholinergic anti-Parkinson agents . . . .  
Dopaminergic anti-Parkinson 
agents . . . . . . . . . . . . . . . . . . . . . .  
Anxiolytics, sedatives, and hypnotics. . . . . .  
Barbiturates. . . . . . . . . . . . . . . . . . . .  
Benzodiazepines . . . . . . . . . . . . . . . .  
Miscellaneous anxiolytics, sedatives and 
hypnotics . . . . . . . . . . . . . . . . . . . .  
CNS  stimulants  . . . . . . . . . . . . . . . . . . .  
General anesthetics . . . . . . . . . . . . . . . .  
Muscle relaxants . . . . . . . . . . . . . . . . . .  
Neuromuscular blocking agents . . . . . . .  
Skeletal muscle relaxants . . . . . . . . . . .  
Miscellaneous central nervous system 
agents. . . . . . . . . . . . . . . . . . . . . . . .  
Anorexiants  . . . . . . . . . . . . . . . . . . . . .  
Cholinesterase inhibitors . . . . . . . . . . . . .  
Coagulation modifiers . . . . . . . . . . . . . . . .  
Anticoagulants . . . . . . . . . . . . . . . . . . .  
Heparins. . . . . . . . . . . . . . . . . . . . . .  
Coumarins and indandiones. . . . . . . . . .  
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Table 8. 
percent 
Annual number and rate of therapeutic categories for drugs 
distribution by setting type: United States, 2006—Con. 
provided, prescribed, or continued at ambulatory care visits and 























Antiplatelet agents . . . . . . . . . . . . . . . . .  
Platelet aggregation inhibitors. . . . . . . . .  
Miscellaneous coagulation modifiers . . . . . .  
Gastrointestinal agents. . . . . . . . . . . . . . . .  
Antacids  . . . . . . . . . . . . . . . . . . . . . . .  
Antidiarrheals . . . . . . . . . . . . . . . . . . . .  
Digestive enzymes . . . . . . . . . . . . . . . . .  
Gallstone solubilizing agents. . . . . . . . . . .  
GI  stimulants  . . . . . . . . . . . . . . . . . . . .  
H2 antagonists . . . . . . . . . . . . . . . . . . .  
Laxatives. . . . . . . . . . . . . . . . . . . . . . .  
Miscellaneous GI agents . . . . . . . . . . . . .  
Proton  pump  inhibitors  . . . . . . . . . . . . . .  
5-aminosalicylates . . . . . . . . . . . . . . . . .  
Functional bowel disorder agents . . . . . . . .  
Anticholinergics/antispasmodics . . . . . . .  
Hormones . . . . . . . . . . . . . . . . . . . . . . .  
Adrenal cortical steroids . . . . . . . . . . . . .  
Glucocorticoids. . . . . . . . . . . . . . . . . .  
Miscellaneous hormones . . . . . . . . . . . . .  
Sex hormones . . . . . . . . . . . . . . . . . . .  
Contraceptives . . . . . . . . . . . . . . . . . .  
Androgens and anabolic steroids. . . . . . .  
Estrogens . . . . . . . . . . . . . . . . . . . . .  
Gonadotropins . . . . . . . . . . . . . . . . . .  
Progestins. . . . . . . . . . . . . . . . . . . . .  
Sex  hormone  combinations  . . . . . . . . . .  
Miscellaneous sex hormones . . . . . . . . .  
5-alpha-reductase inhibitors . . . . . . . . . .  
Thyroid drugs . . . . . . . . . . . . . . . . . . . .  
Bisphosphonates . . . . . . . . . . . . . . . . . .  
Miscellaneous agents . . . . . . . . . . . . . . . .  
Antidotes  . . . . . . . . . . . . . . . . . . . . . . .  
Chelating agents . . . . . . . . . . . . . . . . . .  
Local injectable anesthetics . . . . . . . . . . .  
Miscellaneous uncategorized agents . . . . . .  
Genitourinary tract agents . . . . . . . . . . . .  
Impotence agents . . . . . . . . . . . . . . . .  
Urinary antispasmodics . . . . . . . . . . . .  
Miscellaneous genitourinary tract agents . . 
Antirheumatics . . . . . . . . . . . . . . . . . . .  
Antipsoriatics . . . . . . . . . . . . . . . . . . . .  
Smoking cessation agents . . . . . . . . . . . .  
Nutritional products . . . . . . . . . . . . . . . . . .  
Iron products . . . . . . . . . . . . . . . . . . . .  
Minerals  and  electrolytes  . . . . . . . . . . . . .  
Oral nutritional supplements . . . . . . . . . . .  
Vitamins  . . . . . . . . . . . . . . . . . . . . . . .  
Vitamin  and  mineral  combinations  . . . . . . .  
Respiratory agents . . . . . . . . . . . . . . . . . .  
Antihistamines  . . . . . . . . . . . . . . . . . . .  
Antitussives . . . . . . . . . . . . . . . . . . . . .  
Bronchodilators . . . . . . . . . . . . . . . . . . .  
Adrenergic bronchodilators . . . . . . . . . .  
Bronchodilator combinations . . . . . . . . .  
Anticholinergic bronchodilators . . . . . . . .  
Decongestants . . . . . . . . . . . . . . . . . . .  
Expectorants . . . . . . . . . . . . . . . . . . . .  
Miscellaneous respiratory agents . . . . . . . .  
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Table 8. 
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Annual number and rate of therapeutic categories for drugs 
distribution by setting type: United States, 2006—Con. 
provided, prescribed, or continued at ambulatory care visits and 























Respiratory inhalant products . . . . . . . . . .  
Inhaled corticosteroids . . . . . . . . . . . . .  
Antiasthmatic  combinations  . . . . . . . . . . .  
Upper respiratory combinations . . . . . . . . .  
Leukotriene modifiers . . . . . . . . . . . . . . .  
Topical agents . . . . . . . . . . . . . . . . . . . . .  
Anorectal preparations . . . . . . . . . . . . . .  
Antiseptics and germicides . . . . . . . . . . . .  
Dermatological agents. . . . . . . . . . . . . . .  
Topical  anti-infectives  . . . . . . . . . . . . . .  
Topical  steroids  . . . . . . . . . . . . . . . . .  
Topical anesthetics . . . . . . . . . . . . . . .  
Miscellaneous topical agents . . . . . . . . .  
Topical  steroids  with  anti-infectives  . . . . .  
Topical acne agents. . . . . . . . . . . . . . .  
Topical antipsoriatics . . . . . . . . . . . . . .  
Topical  emollients  . . . . . . . . . . . . . . . .  
Topical  antibiotics  . . . . . . . . . . . . . . . .  
Topical antifungals. . . . . . . . . . . . . . . .  
Mouth and throat products. . . . . . . . . . .  
Ophthalmic preparations . . . . . . . . . . . . .  
Ophthalmic  anti-infectives  . . . . . . . . . . .  
Ophthalmic glaucoma agents . . . . . . . . .  
Ophthalmic  steroids . . . . . . . . . . . . . . .  
Ophthalmic steroids with anti-infectives . . . 
Ophthalmic anti-inflammatory agents . . . .  
Miscellaneous ophthalmic agents . . . . . .  
Ophthalmic antihistamines and 
decongestants . . . . . . . . . . . . . . . . .  
Mydriatics  . . . . . . . . . . . . . . . . . . . . .  
Ophthalmic anesthetics . . . . . . . . . . . .  
Ophthalmic diagnostic agents. . . . . . . . .  
Otic preparations . . . . . . . . . . . . . . . . . .  
Miscellaneous otic agents . . . . . . . . . . .  
Vaginal preparations . . . . . . . . . . . . . . . .  
Vaginal  anti-infectives. . . . . . . . . . . . . .  
Nasal preparations . . . . . . . . . . . . . . . . .  
Nasal steroids . . . . . . . . . . . . . . . . . .  
Nasal antihistamines and decongestants . . 
Alternative  medicines. . . . . . . . . . . . . . . . .  
Nutraceutical products. . . . . . . . . . . . . . .  
Herbal products. . . . . . . . . . . . . . . . . . .  
Psychotherapeutic agents . . . . . . . . . . . . . .  
Antidepressants . . . . . . . . . . . . . . . . . .  
Miscellaneous antidepressants . . . . . . . .  
SSRI antidepressants. . . . . . . . . . . . . .  
Tricyclic antidepressants . . . . . . . . . . . .  
Phenylpiperazine antidepressants . . . . . .  
Tetracyclic antidepressants . . . . . . . . . .  
SSNRI antidepressants . . . . . . . . . . . .  
Antipsychotics. . . . . . . . . . . . . . . . . . . .  
Miscellaneous antipsychotic agents . . . . .  
Phenothiazine antipsychotics . . . . . . . . .  
Atypical antipsychotics . . . . . . . . . . . . .  
Immunologic agents . . . . . . . . . . . . . . . . .  
Bacterial vaccines . . . . . . . . . . . . . . . . .  
Immune  globulins  . . . . . . . . . . . . . . . . .  
Toxoids . . . . . . . . . . . . . . . . . . . . . . . .  
Viral vaccines . . . . . . . . . . . . . . . . . . . .  
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Table 8. 
percent 
Annual number and rate of therapeutic categories for drugs 
distribution by setting type: United States, 2006—Con. 
provided, prescribed, or continued at ambulatory care visits and 























Miscellaneous biologicals . . . . . . . . . . . . .  
Immunosuppressive agents . . . . . . . . . . .  
Interferons  . . . . . . . . . . . . . . . . . . . . . .  
Monoclonal antibodies. . . . . . . . . . . . . . .  
Radiologic agents . . . . . . . . . . . . . . . . . . .  
Radiocontrast agents . . . . . . . . . . . . . . .  
Iodinated  contrast  media. . . . . . . . . . . .  
Metabolic agents . . . . . . . . . . . . . . . . . . .  
Antihyperlipidemic agents . . . . . . . . . . . .  
HMG-CoA reductase inhibitors . . . . . . . .  
Miscellaneous antihyperlipidemic agents . . 
Fibric  acid  derivatives. . . . . . . . . . . . . .  
Bile acid sequestrants . . . . . . . . . . . . .  
Cholesterol absorption inhibitors . . . . . . .  
Antihyperlipidemic combinations . . . . . . .  
Antidiabetic agents. . . . . . . . . . . . . . . . .  
Sulfonylureas. . . . . . . . . . . . . . . . . . .  
Nonsulfonylureas . . . . . . . . . . . . . . . .  
Insulin  . . . . . . . . . . . . . . . . . . . . . . .  
Thiazolidinediones. . . . . . . . . . . . . . . .  
Meglitinides  . . . . . . . . . . . . . . . . . . . .  
Miscellaneous antidiabetic agents . . . . . .  
Antidiabetic combinations . . . . . . . . . . .  
Antigout agents . . . . . . . . . . . . . . . . . . .  
Antihyperuricemic agents . . . . . . . . . . . . .  
Glucose elevating agents. . . . . . . . . . . . .  

























































































































































































































* Figure does not meet standards of reliability or precision. 
0.0 Quantity more than zero but less than 0.05. 
– Quantity zero.
 
1Based on Multum Lexicon first, second, and third level therapeutic drug categories (see www.multum.com/Lexicon.htm).
 
2Total of all therapeutic drug categories will exceed total number of drug mentions because up to four categories may be coded for each drug.
 
3Based on an estimated 2,356,882,000 drug mentions at ambulatory care visits in 2006. A drug mention is defined as any medication that is pro
over-the-counter preparations, immunizations, desensitizing agents, and anesthetics. Up to eight mentions are collected per visit.
 
NOTES: Numbers may not add to totals because of rounding. Also, categories with less than 30 unweighted total occurrences were not included
Medical Care Survey included a sample of community health centers (CHCs) in addition to the traditional sample of office-based physicians. Es
office-based physicians as defined by the American Medical Association as well as data from a sample of physicians working in CHCs. 
vided, prescribed,
 in this table. The
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